Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

48.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
48.8K
Homologous Recombination02:31

Homologous Recombination

50.0K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

16.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An encyclopedia of human enhancer-gene regulatory interactions.

Nature·2026
Same author

Biological aging clocks in health and disease.

Nature medicine·2026
Same author

Towards the construction of a virtual yeast.

Nature·2026
Same author

Harmonizing standards and resources for the medical genome.

Nature·2026
Same author

Evaluating the robustness and readiness of large frontier models in health AI applications.

Nature medicine·2026
Same author

Correction: Phase I/II, open-label, multicenter study of durvalumab in combination with tremelimumab in pediatric patients with advanced solid tumors.

Frontiers in oncology·2026

Related Experiment Video

Updated: May 23, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
00:09

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

21.6K

A CRISPR/Cas9-based enhancement of high-throughput single-cell transcriptomics.

Amitabh C Pandey1,2,3, Jon Bezney4,5,6, Dante DeAscanis5

  • 1Section of Cardiology, Tulane Heart and Vascular Institute, Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA. apandey@tulane.edu.

Nature Communications
|May 19, 2025
PubMed
Summary

Single-cell CRISPRclean (scCLEAN) is a novel molecular method that improves single-cell RNA sequencing (scRNAseq) by removing abundant transcripts. This enhances the detection of low-abundance transcripts, revealing deeper biological insights.

More Related Videos

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.2K
Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

13.0K

Related Experiment Videos

Last Updated: May 23, 2025

Pooled CRISPR-Based Genetic Screens in Mammalian Cells
00:09

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

21.6K
Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines
10:46

Dissection of Enhancer Function Using Multiplex CRISPR-based Enhancer Interference in Cell Lines

Published on: June 2, 2018

9.2K
Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on: January 5, 2018

13.0K

Area of Science:

  • Molecular Biology
  • Genomics
  • Bioinformatics

Background:

  • Single-cell RNA sequencing (scRNAseq) faces challenges in detecting low-abundance transcripts due to interference from highly abundant ones.
  • This limitation obscures cellular heterogeneity and hinders the discovery of subtle biological signatures within cell populations.

Purpose of the Study:

  • To introduce single-cell CRISPRclean (scCLEAN), a molecular method designed to enhance transcript detection in scRNAseq.
  • To demonstrate scCLEAN's capability to improve the discovery of biologically relevant transcripts, particularly those expressed at low levels.

Main Methods:

  • scCLEAN employs CRISPR/Cas9 technology to selectively target and remove highly abundant transcripts from scRNAseq libraries.
  • This process recomposes the library, redistributing sequencing reads to focus on less abundant, biologically significant transcripts.
  • The method was applied to heterogeneous immune cells and homogenous vascular smooth muscle cells, and integrated with single-cell MAS-Seq.

Main Results:

  • scCLEAN successfully enhanced the detection of low-abundance transcripts across different cell types and biological contexts.
  • The method demonstrated increased transcript-level detection and discovery when applied to third-generation sequencing (single-cell MAS-Seq).
  • Experimental applications revealed distinct biological signatures that were previously obscured by abundant transcripts.

Conclusions:

  • scCLEAN offers a significant advancement in scRNAseq by overcoming the limitations of transcript abundance variability.
  • The technology shows broad utility across various human tissues and cell types, improving the resolution of single-cell transcriptomic analysis.
  • The study provides guidance on the optimal contexts for applying scCLEAN to maximize its benefits in biological discovery.